Cancer Treatment with Natural Products – Phytochemicals
Oncology-Phytochemicals
Keywords:
Phytochemicals, Berberine, Ellagic acid, Icariin, Natural Products for Cancer, GenisteinAbstract
Since over forty years ago, numerous studies have been conducted on the anticancer potential of natural compounds, which have a surprising chemical variety. Society's collective endeavors have made enormous strides, introducing natural products into clinical usage and uncovering novel therapeutic possibilities, but there are still obstacles to overcome. We might have reached a turning point when we need to review the approaches to comprehend nature's products and investigate their therapeutic efficacy due to the striking changes in the landscape of cancer therapy and the expanding involvement of advanced technology. For being able to revive the search for natural goods as cancer therapies, this review highlights the major developments in natural product-centered cancer research and argues for the adoption of systematic methodologies and the development of novel pharmacological models, including the investigation of future avenues. It is because many natural products contain compounds that have been found to have beneficial effects against cancer, and these compounds can be used in combination with traditional therapies to increase efficacy and reduce side effects. Additionally, systematic methodologies and novel pharmacological models can help identify potential new therapies or combinations that would be more effective than traditional treatments. Natural products can also be used as preventive measures to reduce the risk of developing cancer. Furthermore, natural products can reduce the toxicity of traditional treatments and improve the quality of life for cancer patients. Moreover, natural products can be safely integrated into existing treatments to maximize the efficacy of treatment plans.
References
Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia MM, Miranda-Filho A, Ferlay J et al. Cancer survival in Africa, Central and South America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncol. 2023 Jan 1;24(1):22-32. doi: 10.1016/S1470-2045(22)00704-5, PMID 36603919.
Vodicka P, Vodenkova S, Horak J, Opattova A, Tomasova K, Vymetalkova V et al. An investigation of DNA damage and repair in chemical carcinogenesis triggered by small-molecule xenobiotics and cancer: thirty years with the comet assay. Mutat Res Genet Toxicol Environ Mutagen. 2023;885:503564. doi: 10.1016/j.mrgentox.2022.503564.
Lowy DR, Fiore MC, Willis G, Mangold KN, Bloch MH, Baker TB. Treating Smoking in Cancer Patients: an Essential Component of Cancer Care-The New National Cancer Institute Tobacco Control Monograph. JCO Oncol Pract. 2022 Dec;18(12):e1971-6. doi: 10.1200/OP.22.00385, PMID 36343305.
Hagan ML, Mander S, Joseph C, McGrath M, Barrett A, Lewis A, et al. Upregulation of the EGFR/MEK1/MAPK1/2 signaling axis as a resistance mechanism to antiestrogen-induced BimEL-dependent apoptosis in ER+ breast cancer cells. Int J Oncol. 2023 Feb 1;62(2):1-6. doi: 10.3892/ijo.2022.5468, PMID 36524361.
Amaldoss MJN, Mehmood R, Yang JL, Koshy P, Kumar N, Unnikrishnan A, et al. The anticancer therapeutic effect of cerium-based nanoparticles: known and unknown molecular mechanisms. Biomater Sci. 2022;10(14):3671-94. doi: 10.1039/d2bm00334a, PMID 35686620.
Singh D, Kumari K, Ahmed S. Natural herbal products for cancer therapy. In understanding cancer 2022 Jan 1 (pp. 257-68). Academic Press.
Eisen L. Personal protection measures to prevent tick bites in the United States: knowledge gaps, challenges, and opportunities. Ticks Tick Borne Dis. 2022 Mar 26;13(4):101944. doi: 10.1016/j.ttbdis.2022.101944, PMID 35364518.
Muhammad N, Usmani D, Tarique M, Naz H, Ashraf M, Raliya R, et al. The role of natural products and their multitargeted approach to treat solid cancer. Cells. 2022 Jul 15;11(14):2209. doi: 10.3390/cells11142209, PMID 35883653.
Desai N, Patro V. Modalities of anticancer treatment and its perioperative implications. A complete guide to onco-anesthesia, critical care, and cancer pain. Vol. 23; 2022 Jun 23.
Hassanein EHM, Ibrahim IM, Abd-Alhameed EK, Mohamed NM, Ross SA. Protective effects of berberine on various kidney diseases: emphasis on the promising effects and the underlined molecular mechanisms. Life Sci. 2022 Jun 16;306:120697. doi: 10.1016/j.lfs.2022.120697, PMID 35718235.
Alsabeelah N, Kumar V. Quality by design‐based optimization of formulation and process parameters for berberine nanosuspension for enhancing its dissolution rate, bioavailability, and cardioprotective activity. J Food Biochem. 2022 Oct;46(10):e14361. doi: 10.1111/jobs.14361, PMID 35929374.
ALTamimi JZ, Alshammari GM, AlFaris NA, Alagal RI, Aljabryn DH, Albekairi NA et al.Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK. Pharm Biol. 2022 Jan 1;60(1):25-37. doi: 10.1080/13880209.2021.1990969, PMID 34870551.
Campos M, Lameu C, Chamelete A, Lima A, Cândido N, Ulrich P et al. Purinergic Receptor Antagonist A438079 Disrupts Benzo[a] pyrene-Mediated IL-1β, CYP1A and CYP1B Transcript Induction Pathway in Zebrafish: Insights into Possible Mechanisms. Ecotoxicol Environ Contam. 2022;17(2):78-84. doi: 10.5132/eec.2022.02.09.
Eidizade F, Soukhtanloo M, Zhiani R, Mehrzad J, Mirzavi F. Inhibition of glioblastoma proliferation, invasion, and migration by urolithin B through inducing G0/G1 arrest and targeting MMP-2/−9 expression and activity. BioFactors. 2023;49(2):379-89. doi: 10.1002/of.1915, PMID 36310375.
Ferreira HRP, Cabral RLB, Queiroga TBD, Guedes PMM, Lourenço de Assis AB, de Moura Barbosa T et al. The repellency effect of icaridin nanostructural solution applied on cotton knitting fabric against Lutzomyia longipalpis. Parasitol Res. 2022 Sep;121(9):2673-81. doi: 10.1007/s00436-022-07595-4, PMID 35821144.
Mir MA, Gul A, Sofi S, Khan MS. CDk inhibitor for treatment of breast cancer. InTherapeutic potential of cell cycle kinases in breast cancer 2023 Mar 4 (pp. 313-33). Singapore: Springer Nature Singapore.
Momen Razmgah M, Ghahremanloo A, Javid H, AlAlikhan A, Afshari AR, Hashemy SI. The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells. Mol Biol Rep. 2022 Oct;49(10):9307-14. doi: 10.1007/s11033-022-07771-w, PMID 35960409.
Kuksal A, Kunder M, Balakrishna S. Effect of α1-AT on VEGF and MMP-2 in HUVECs exposed to high glucose and hypoxia: a possible therapeutic approach towards diabetic retinopathy. Rom J Diabetes Nutr Metab Dis. 2022 Sep 30;29(3):310-5.
Yadav B, Yadav RK, Srivastav G, Yadav RA. Experimental Raman, FTIR and UV-vis spectra, DFT studies of molecular structures and barrier heights, thermodynamic functions and bioactivity of kaempferol. J Mol Struct. 2022 Jun 15;1258:132637. doi: 10.1016/j.molstruc.2022.132637.
Sengupta B, Biswas P, Roy D, Lovett J, Simington L, Fry DR et al. Anticancer properties of kaempferol on cellular signaling pathways. Curr Top Med Chem. 2022;22(30):2474-82. doi: 10.2174/1568026622666220907112822, PMID 36082856.
Karuppaiya P, Wu J. Production of podophyllotoxin, kaempferol, and quercetin in callogenesis of Dysosma versipellis—an endangered medicinal plant. S Afr J Bot. 2022 Dec 1;151:360-6. doi: 10.1016/j.sajb.2022.03.022.
Juárez-Chairez MF, Meza-Márquez OG, Márquez-Flores YK, Jiménez-Martínez C. Potential anti-inflammatory effects of legumes: a review. Br J Nutr. 2022 Dec;128(11):2158-69. doi: 10.1017/S0007114522000137, PMID 35042569.
Cruz-Gregorio A, Aranda-Rivera AK, Sciutto E, Fragoso G, Pedraza-Chaverri J. Redox state associated with antitumor and immunomodulatory peptides in cancer. Arch Biochem Biophys. 2022 Sep 26;730:109414. doi: 10.1016/j.abb.2022.109414, PMID 36174750.
Anand K, Kumar V, Prasher IB, Sethi M, Raj H, Ranjan H, et al. Bioactive molecules from fungal endophytes and their applications in pharmaceutical industries: challenges and future scope. J Basic Microbiol. 2023. doi: 10.1002/jobm.202200696, PMID 36998101.
Vinolia R, Philomina AF, Yasmin M. Identification of phytochemical compounds from the ethanolic extract of Gymnema Sylvestre, Senna auriculata, and Cissus quadrangularis.
Choudhari J, Nimma R, Nimal SK, Totakura Venkata SK, Kundu GC, Gacche RN. Prosopis juliflora (Sw.) DC phytochemicals induce apoptosis and inhibit cell proliferation signaling pathways, EMT, migration, invasion, angiogenesis, and stem cell markers in melanoma cell lines. J Ethnopharmacol. 2023 Apr 14;312:116472. doi: 10.1016/j.jep.2023.116472, PMID 37062530.
Nava-Tapia DA, Cayetano-Salazar L, Herrera-Zúñiga LD, Bello-Martínez J, Mendoza-Catalán MA, Navarro-Tito N. Brazilin: biological activities and therapeutic potential in chronic degenerative diseases and cancer. Pharmacol Res. 2022 Jan 1;175:106023. doi: 10.1016/j.phrs.2021.106023, PMID 34883212.
Song Y, Bi Z, Liu Y, Qin F, Wei Y, Wei X. Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: current status in clinical trials. Genes Dis. 2023;10(1):76-88. doi: 10.1016/j.gendis.2022.05.006.
Huang M, Lu JJ, Ding J. Natural products in cancer therapy: past, present and future. Nat Prod Bioprospect. 2021;11(1):5-13. doi: 10.1007/s13659-020-00293-7, PMID 33389713.
Natarajan PM, Umapathy VR, Murali A, Swamikannu B. Computational simulations of identified marine-derived natural bioactive compounds as potential inhibitors of oral cancer. Future Sci OA, published online on 2022. 2022;8(3):FSO782. doi: 10.2144/fsoa-2021-0148, PMID 35251696.
Umapathy VR, Natarajan PM, Swamikannu B, Moses J, Jones S, Chandran MP et al. Emerging Biosensors for Oral Cancer Detection and Diagnosis-A Review Unravelling Their Role in Past and Present Advancements in the Field of Early Diagnosis. Biosensors. 2022;12(7):498. doi: 10.3390/bios12070498, PMID 35884301.
Umapathy VR, Natarajan PM, SumathiJones C, Swamikannu B, Johnson WMS, Alagarsamy V et al. Current trends and future perspectives on dental nanomaterials – an overview of nanotechnology strategies in dentistry. J King Saud Univ Sci. 2022;34(7):102231. doi: 10.1016/j.jksus.2022.102231.
Rekha U V, Mn P, S B. Review on Anticancer properties of piperine in Oral cancer: therapeutic Perspectives. Res J Pharm Technol. 2022;15(7):3338-42. doi: 10.52711/0974-360X.2022.00558.
Umapathy VR, Natarajan PM, Swamikannu B. Comprehensive review on development of early diagnostics on oral cancer with a special focus on biomarkers. Appl Sci. 2022;12(10):4926. doi: 10.3390/app12104926.
Pei J, Palanisamy CP, Alugoju P, Anthikapalli NVA, Natarajan PM, Umapathy VR et al. A comprehensive review on bio-based materials for chronic diabetic wounds. Molecules. 2023;28(2):604. doi: 10.3390/molecules28020604, PMID 36677658.
Natarajan P, Rekha V, Murali A, Swamikannu B. Newer congeners of doxycycline – do they hold promise for periodontal therapy?. amscd. 2022;7(1):16-23. doi: 10.5114/amscd.2022.119600.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Dr M.R. Suchitra, Ranjeet Kumar Chourasia, Vidhya Rekha Umapathy, A. Vinita Mary, Dr. Kesavan.R, Dr. Ranjani.D
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
